Sponsor Dossier
Helix Pharmaceuticals
Sponsor Dossier for Helix Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ARX-FLUTICASONE
- Brand: AZITHROMYCIN
- Brand: DASATINIB VIATRIS
- Brand: DUTASTERIDE/TAMSULOSIN
- Brand: DUTASTERIDE/TAMSULOSIN-WGR
- Brand: FLUTICAMYS
- Brand: FLUTICASONE
- Brand: FLUTICASONE-RKM
About
Helix Pharmaceuticals is an Australian Fixed Unit Trust with ABN 57 180 377 631, registered in Victoria. The entity is active and registered for GST.
Portfolio
Helix Pharmaceuticals has 16 brands on the ARTG, of which 13 are indexable and 11 carry a Product Information document. 9 brands are PBS-listed, 0 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include ARX-FLUTICASONE, AZITHROMYCIN, DASATINIB VIATRIS, DUTASTERIDE/TAMSULOSIN, DUTASTERIDE/TAMSULOSIN-WGR, FLUTICAMYS, FLUTICASONE, FLUTICASONE-RKM, FLUTICASONE-WGR, MELOXICAM VIATRIS, MODAFINIL, NEBIVOLOL VIATRIS.
Therapeutic focus
— Respiratory: 5 brands — Oncology: 2 brands — Reproductive Health: 2 brands — Cardiology: 2 brands — Infectious Disease: 1 brand — Gastroenterology: 1 brand — Psychiatry: 1 brand — Musculoskeletal: 1 brand — Neurology: 1 brand
PBS footprint
9 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.